Erratum

Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis

Authors

Eizo Saito¹, Takao Koike², Hiroshi Hashimoto³, Nobuyuki Miyasaka⁴, Yasuo Ikeda⁵, Masako Hara⁶, Hidehiro Yamada⁷, Tadashi Yoshida⁸, Masayoshi Harigai⁶, Yoichi Ichikawa⁹ and Additional members of the GB-0998 Study Group

1. Department of Rheumatology, Toho University Ohashi Medical Center, 2-17-6 Ohashi, Meguro-ku, Tokyo 153-8515, Japan
2. Department of Medicine II, Hokkaido University Graduate School of Medicine, Kita 15 Nishi 7, Kita-ku, Sapporo, Hokkaido 060-8638, Japan
3. Division of Rheumatology, Department of Internal Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
4. Department of Medicine & Rheumatology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
5. Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
6. Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawadacho, Shinjuku-ku, Tokyo 162-0054, Japan
7. Division of Rheumatology and Allergy, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-0015, Japan
8. Department of Pathophysiology, Faculty of Pharmaceutical Science, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan
9. St. Joseph’s Hospital, 28 Midorigaoka, Yokosuka, Kanagawa 238-8502, Japan

Published online:

25 March 2008

Full Text

PDF

Without Abstract

The online version of the original article can be found under doi:10.1007/s10165-007-0013-0.